Myrtle S. Potter, Director at Guardant Health, Inc. (GH), sold 5,252 shares at $49.70 ($261K) on 2025-06-16, disclosed to the SEC on 2025-06-16.
Scheduled sale ($261k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.70 | 2,626 | $131K | 50.0% |
| 2 | $49.70 | 2,626 | $131K | 50.0% |
| Total | $49.70 avg | 5,252 | $261K | 100% |
| Filing → |
| GH | SELL | 2025-09-17 | $1K | — | Filing → |
| GH | SELL | 2025-08-20 | $2K | — | Filing → |
| GH | SELL | 2025-07-18 | $1K | — | Filing → |